Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 1 Mar 2002

Scheuer Lauren, Kauff Noah, Robson Mark, Kelly Bridget, Barakat Richard, Satagopan Jaya, Ellis Nathan, Hensley Martee, Boyd Jeff, Borgen Patrick, Norton Larry, Offit Kenneth

Abstract excerpt

PURPOSE: To prospectively determine the impact of genetic counseling and testing on risk-reduction strategies and cancer incidence in a cohort of individuals at hereditary risk for breast and ovarian cancer. PATIENTS AND METHODS: Two hundred fifty-one individuals with BRCA mutations were identified at a single comprehensive cancer center from May 1, 1995, through October 31, 2000. Uniform recommendations...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Fallopian Tube Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, BRCA1

Share to Genes, BRCA2

Share to Genetic Counseling

Share to Genetic Testing

Share to Ovarian Neoplasms

Share to Ovariectomy

Source

Identifiers

PMID: 11870168
DOI: 10.1200/JCO.2002.20.5.1260

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers.PMID 11870168Read ↗

Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.Semantic proximity Read ↗

Risk-reducing salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

Risk-reducing surgery in unaffected individuals receiving cancer genetic testing in an integrated health care system.Semantic proximity Read ↗

Pathologic findings at risk-reducing salpingo-oophorectomy: primary results from Gynecologic Oncology Group Trial GOG-0199.Semantic proximity Read ↗

Prediction of Cancer Prevention: From Mammogram Screening to Identification of BRCA1/2 Mutation Carriers in Underserved Populations.Semantic proximity Read ↗

Clinical characteristics and choices regarding risk-reducing surgery in BRCA mutation carriers.Semantic proximity Read ↗

Genetic testing for a BRCA1 mutation: prophylactic surgery and screening behavior in women 2 years post testing.Semantic proximity Read ↗

Clinical and pathological outcomes of risk-reducing salpingo-oophorectomy for Japanese women with hereditary breast and ovarian cancer.Semantic proximity Read ↗

Cancer prevention and screening practices among women at risk for hereditary breast and ovarian cancer after genetic counseling in the community setting.Semantic proximity Read ↗

Implementation of Risk-Reducing Surgery for HBOC Under Public Insurance in Japan: A Single-Center ExperienceSemantic proximity Read ↗

Risk-reducing decisions regarding germline BRCA pathogenic variant: focusing on the timing of genetic testing and RRSO.Semantic proximity Read ↗

Risk-reducing surgery, screening and chemoprevention practices of BRCA1 and BRCA2 mutation carriers: a prospective cohort study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.